Brice Gaudilliere
Has grant
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
Open Date: 2021-08-01
Close Date: 2026-07-31
Grant: Close
Harnessing the human monocyte system to improve surgical recovery
Open Date: 2020-08-01
Close Date: 2025-11-30
Articles (9)
Neonatal prematurity leads to considerable morbidity and mortality, partly because of acquired conditions such as bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), and retinopathy of prematurity (ROP). Standard gestational age and birthweight-based classifications of prematurity inadequately capture the variation in newborns’ health outcomes, creating an urgent need to develop risk stratification tools for vulnerable newborn infants to initiate the most appropriate care pathways as early as possible. We hypothesized that the metabolic profiles of newborn infants capture additional risk information beyond current measures. A total of 13,536 newborn screening (NBS) blood spot tests from preterm infants in California with linked clinical outcomes of prematurity were used to develop an NBS-based metabolic health index to stratify preterm infants at risk for BPD, IVH, NEC, and ROP (12,096 cases with one or more conditions and 1440 controls) through a deep learning model that provides a single index score in tandem with subgroup discovery to identify individuals with the strongest metabolite biomarker signals for adverse outcomes of prematurity. This metabolic health index captured risk signals that were distinct from gestational age and birthweight and outperformed other machine learning algorithms and clinical risk variable-based models in stratifying at-risk individuals for adverse outcomes of prematurity. The metabolic health index was externally validated in an independent retrospective cohort of 3299 very premature newborns from Ontario, Canada (2117 cases and 1182 controls), which recapitulated common metabolic risk subgroups. In summary, combining widespread metabolite screening with deep learning established a generalizable biological risk metric of prematurity.
Year:
2026
Preeclampsia is a life-threatening pregnancy disorder with significant maternal and neonatal implications, and few diagnostic and therapeutic strategies. In this study, we integrated six placental transcriptomic datasets to identify a robust preeclampsia-specific gene signature, which revealed key dysregulated processes, including hypoxia, immune dysfunction, and metabolic disruption. We applied Multivariate INTegrative (MINT) integration to derive a smaller, predictive gene signature optimized for biomarker discovery. Validation in a longitudinal blood dataset demonstrated its potential as blood-based biomarkers for early diagnosis and monitoring. Using the meta-analysis signature, we conducted a drug repurposing analysis that identified 63 candidate therapeutics for preeclampsia. Lansoprazole, a widely available proton pump inhibitor with a favorable safety profile, emerged as the top candidate. Preclinical evaluation using a mouse preeclampsia model triggered by partial depletion of maternal FOXP3+ regulatory CD4 T cells showed lansoprazole treatment overrides normally increased soluble FLT1 levels with protection against fetal wastage. Together integrating computational and experimental approaches lays the foundation for further investigating lansoprazole as a therapeutic candidate for preeclampsia.
Year:
2026
Objectives We investigated whether palmar cooling alters inflammatory responses following a single session of high-intensity eccentric exercise. We hypothesized that palmar cooling during rest intervals would attenuate maladaptive inflammatory responses while preserving beneficial immune adaptations necessary for muscle repair and recovery. Methods In this randomized interventional study, 20 healthy adults were matched by sex and one-repetition maximum (1RM) for bicep curls. Participants performed 10 sets at 70% 1RM, receiving either palmar cooling at 14ºC or a thermoneutral control at 30ºC during 3-minute inter-set rest periods. Whole blood was collected at baseline, immediately post-exercise, and on post-exercise days 1, 2, and 4 for comprehensive immune profiling with mass cytometry. Blood lactate and pain scores were also recorded. Results Exercise induced broad immunosuppression that was significantly attenuated in the palmar cooling group by 2 days post-exercise (AUC=0.79, p =0.03). The cooled group had decreased immunosuppressive activity and increased inflammatory innate immune mechanisms in the cooled group. Palmar cooling also significantly reduced lactate levels compared to controls ( p =0.024). Conclusion Palmar cooling at 14ºC during rest intervals effectively modulated the immune response to high-intensity exercise and reduced lactate accumulation. These findings suggest palmar cooling may serve as a promising intervention to mitigate exercise-induced immunosuppression and support recovery. Trial identifier NCT07215338 (retrospectively registered). Summary Box What is already known on this topic High intensity eccentric exercise contributes to physiological heat stress which induces significant immune alterations that can lead to a transient period of immunosuppression and increased incidence of respiratory tract infections . What this study adds Palmar cooling resulted in cell-type-specific alterations in innate and adaptive immune cell signaling activity, particularly decreasing immunosuppressive cell responses while enhancing inflammatory innate immune mechanisms implicated in pathogen defense . How this study might affect research, practice or policy Palmar cooling may serve as an effective intervention for managing exercise-induced immunosuppression and supporting recovery in athletes. Integration of palmar cooling techniques into athletic training regimens and rehabilitation protocols can ultimately enhance exercise performance and reduce the adverse effects associated with high-intensity exercise .
Year:
2025
Vγ9Vδ2 (TCRVγ9 + TCRVδ2 + ) T cells are promising immunotherapeutic targets with effective antitumor properties in both in vitro and preclinical models of triple-negative breast cancer (TNBC). However, no information about their potential role in the context of human TNBC progression and response to immunotherapy has been reported. One key reason for this is the scarcity of Vγ9Vδ2 T-cell infiltrates relative to their Vδ1 (TCRVδ1 + ) and αβCD8 (TCRαβ + CD8αβ + ) T-cell counterparts. We provide comprehensive single-cell profiling of Vγ9Vδ2 T cells from patients with TNBC, prior to and following PD-(L)1 blockade therapy. We report that baseline Vγ9Vδ2 T-cell infiltrate expressing a unique cytotoxic type I phenotype could be associated with improved survival in patients with TNBC. Vγ9Vδ2 T cells harboring characteristics of enhanced antitumor activity ( KLRC1 + ) were further associated with improved response to PD-(L)1 blockade therapy in patients with TNBC. Vγ9Vδ2 T cells had low expression levels of T-cell exhaustion (PD-1 Low TOX Low ) and T-cell receptor signaling hallmarks compared with Vδ1 and αβCD8 T cells, along with skewed differentiation profiles toward early effector memory phenotypes, both before and after anti–PD-1 therapy in TNBC tumors. Consistently, we observed limited activity of anti–PD-1 on tumor-infiltrating Vγ9Vδ2 T cells. In vitro , the use of anti–butyrophilin-3A antibodies in addition to anti–PD-1 reinvigorated the cytotoxic type I functions of peripheral Vγ9Vδ2 T cells from patients with breast cancer. Together, these data provide a rationale for Vγ9Vδ2 T cell–based combination therapy in patients with TNBC.
Year:
2025
Endometriosis has limited treatment options, prompting the search for novel therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline to analyze public bulk transcriptomic data of eutopic endometrium from cases and controls and identified several drug candidates. Fenoprofen, our top in silico candidate, was validated in a rat model of endometriosis-associated pain. Building on this, we evaluated herein two additional candidates, simvastatin (a cholesterol-lowering drug) and primaquine (an antimalarial), based on strong endometrial gene expression reversal scores and favorable safety profiles. Using the rat model, we conducted behavioral testing, bulk RNA sequencing, and differential expression analysis to assess their therapeutic potential. We also assessed endometriosis diagnosis among patients prescribed simvastatin in electronic medical records (EMR) across six University of California (UC) healthcare institutions. In vivo validation using a rat model of endometriosis demonstrated that both simvastatin and primaquine significantly reduced vaginal hyperalgesia, a surrogate marker of endometriosis-related pain. RNA-seq of uteri and lesions confirmed reversal of disease-associated gene expression signatures following treatment. Analysis of UC-wide EMR data found lower relative risk of endometriosis among those prescribed simvastatin compared to a matched control group. Overall, simvastatin and primaquine attenuated pain-associated behaviors and reversed endometriosis-related gene expression changes in an animal model. Moreover, simvastatin prescription was associated with a lower relative risk of endometriosis in our retrospective multi-center cohort study. These findings highlight their potential as repurposed therapeutics for endometriosis and support the effectiveness of computational drug repositioning in identifying new treatment strategies. One Sentence Summary Simvastatin and primaquine reduced endometriosis pain and reversed gene signatures, with simvastatin also linked to lower disease risk.
Year:
2025
Postoperative pancreatic fistula (POPF) is the major driver of postoperative morbidity after pancreatoduodenectomy (PD). However, current preoperative prediction models lack precision. This study aimed to determine the ability of a high dimensional analysis from the patient’s peripheral immune system before PD using mass cytometry and sparse machine learning (ML), to predict POPF. Twenty-two patients in the prospective IMMUNOPANC trial (NCT03978702) underwent PD. Blood samples collected preoperatively were analyzed by combining single-cell mass cytometry and a new sparse ML pipeline, Stabl, to identify the most relevant POPF-predictive features. The logistic regression model output was evaluated using a five-fold cross-validation procedure. Eight (36%) patients experienced POPF (grade B, n = 7; grade C, n = 1). The multivariable predictive model comprised 11 features—six natural killer, three CD8 + T, and two CD4 + T lymphocyte cell clusters—revealing a preoperative POPF lymphocyte signature (Pancreatic Fistula Lymphocyte Signature, PFLS). The Stabl algorithm identified a predictive model classifying POPF patients with high performance (area under the receiver operating characteristic curve = 0.81, P = 2.04e-02). In summary, preoperative circulating immune-cell composition can predict POPF in patients undergoing pancreatoduodenectomy. Clinical application of the PFLS could potentially help identify high-risk populations and mitigate POPF risk.
Year:
2025
Immune suppression heightens the risk for fungal infections, but the mechanisms that result in clinical disease are poorly understood. Here we demonstrate that macrophage ferroptosis, an iron-dependent form of regulated cell death, inhibits Aspergillus fumigatus ( Af ) killing. In a mouse tracheal transplant model of Af infection, we observed an increase in macrophage lipid peroxidation, a decreased expression of negative ferroptosis regulators Gpx4 and Slc7a11 , and an increase in positive regulators Ptgs2 and Nox2 , relative to syntransplants. Depletion of macrophages in transplant recipients decreased Af invasion. In vitro , iron overload reduced macrophage viability and decreased their capability to kill Af spores, through a decrease in lysosomal acidification and lysosomal loss. Treatment with ferrostatin-1, a ferroptosis inhibitor, and deferasirox (an iron chelator) restored Af killing. Ferroptotic alveolar macrophages isolated from lung transplant patients also showed a decreased ability to kill Af spores and the patients’ bronchoalveolar lavage was characterized by higher iron levels and markers of ferroptotic stress compared to non-lung transplants. These characteristics were strongly correlated with a clinical history of fungal infections, independent of immune suppressive medications. Our findings indicate that macrophage ferroptosis augments the risk of invasive aspergillosis, representing a novel mechanism for host immune dysfunction. Graphical Abstract Schematic of proposed mechanism underlying ferroptosis induced immune dysregulation and increased Af invasion in lung transplantation.
Year:
2025
High throughput sequencing is a powerful tool for processing large amounts of DNA and RNA samples in batches. Proper experimental design and statistical methods are required to mitigate systematic technical factors due to differences in batches (“batch effects”), as data variation due to these non-biological factors can mask actual biological differences. We propose using anticlustering as an automated method to assign samples to balanced batches. Anticlustering effectively negates differences in (numeric and/or categorical) covariates among batches, and implements user-defined restrictions on the number of batches, the number of samples per batch, and whether to assign certain samples to the same batch (“must-link constraints”). A simulation study shows that anticlustering is better at achieving balance among batches than previous approaches. An application from the UCSF-Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement (“ENACT”, https://enactcenter.org/ ) is presented as a real-life example. In the application, multiple samples provided by an individual had to be processed on the same batch, so that comparisons among different samples of the same patient were not diluted by batch effects. The novel Two Phase Must Link (2PML) anticlustering algorithm realized the must-link restrictions while simultaneously obtaining balance among batches regarding disease stage, menstrual cycle phase, case versus control sample, and clinical site. All methods presented here are accessible via the free and open source R package anticlust ( https://cran.r-project.org/package=anticlust ). An interactive visualization and web-based batch assignment tool are made available in the Rshiny app “anticlust” ( https://anticlust.org/ ).
Year:
2025
Background: Postoperative cognitive decline (POCD) is the predominant complication affecting patients over 60 years old following major surgery, yet its prediction and prevention remain challenging. Understanding the biological processes underlying the pathogenesis of POCD is essential for identifying mechanistic biomarkers to advance diagnostics and therapeutics. This study aimed to provide a comprehensive analysis of immune cell trajectories differentiating patients with and without POCD and to derive a predictive score enabling the identification of high-risk patients during the preoperative period. Material and methods: Twenty-six patients aged 60 years old and older undergoing elective major orthopedic surgery were enrolled in a prospective longitudinal study, and the occurrence of POCD was assessed 7 days after surgery. Serial samples collected before surgery, and 1, 7, and 90 days after surgery were analyzed using a combined single-cell mass cytometry and plasma proteomic approach. Unsupervised clustering of the high-dimensional mass cytometry data was employed to characterize time-dependent trajectories of all major innate and adaptive immune cell frequencies and signaling responses. Sparse machine learning coupled with data-driven feature selection was applied to the presurgery immunological dataset to classify patients at risk for POCD. Results: The analysis identified cell-type and signaling-specific immune trajectories differentiating patients with and without POCD. The most prominent trajectory features revealed early exacerbation of JAK/STAT and dampening of inhibitory κB and nuclear factor-κB immune signaling responses in patients with POCD. Further analyses integrating immunological and clinical data collected before surgery identified a preoperative predictive model comprising one plasma protein and 10 immune cell features that classified patients at risk for POCD with excellent accuracy (AUC=0.80, P =2.21e-02 U -test). Conclusion: Immune system-wide monitoring of patients over 60 years old undergoing surgery unveiled a peripheral immune signature of POCD. A predictive model built on immunological data collected before surgery demonstrated greater accuracy in predicting POCD compared to known clinical preoperative risk factors, offering a concise list of biomarker candidates to personalize perioperative management.
Year:
2024
Collaborators (27)
Philippe ROCHIGNEUX
Associate Professor
Aix-Marseille University
François Bertucci
Professor
Institut Paoli-Calmettes
tomiko oskotsky
University of California, San Francisco
Jatin Vyas
Roy and Diana Professor of Medicine - tenured
Columbia University
Manuela Helmer-Citterich
professor
University of Rome Tor Vergata
Kumanan Wilson
Ottawa Hospital
Gundeep Dhillon
Stanford University
Martin Papenberg
Heinrich Heine University Düsseldorf
Franck Verdonk
Stanford University
Karl G. Sylvester
Stanford University School of Medicine
Chi-Hung Shu
Stanford University
Boris Oskotsky
University of California, San Francisco
Dyani Gaudilliere
Clinical Assistant Professor, Chief of Dental Medicine & Surgery
Stanford University
Linda C Giudice
Distinguished Professor
University of California, San Francisco
Husham Sharifi
Stanford University
Joe L. Hsu
Assistant professor
Stanford University School of Medicine
gilles houvenaeghel
Institut Paoli-Calmettes
Marina Sirota
University of California, San Francisco
daniel olive
Professeur des Universités-Praticien Hospitalier
Aix-Marseille University
Jonathan Reiss
Stanford University
Jarrod Fortwendel
Professor
University of Tennessee Health Science Center
Anthony Gonçalves
Aix-Marseille University
Martin Angst
Professor
Stanford University School of Medicine
Feng Xie
Assistant Professor
University of Minnesota Twin Cities
Henry Lee
University of California, San Diego
H Craig Heller
Professor
Stanford University
Gunnar W. Klau
Professor
Heinrich Heine University Düsseldorf
Make your next move.
Prepare your application
Review drafts before you send them.